SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-04-173865
Filing Date
2004-10-19
Accepted
2004-10-19 17:25:04
Documents
9
Period of Report
2004-10-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 27078
2 AMENDMENT NO. 1 TO AGREEMENT dex101.htm EX-10.1 18019
3 FORM OF REVISED CONTINGENT VALUE RIGHTS AGREEMENT dex991.htm EX-99.1 272535
4 VOTING AGREEMENT, & CERTAIN ENTITIES AFFILIATED WITH TANG CAPITAL PARTNERS, L.P dex992.htm EX-99.2 70900
5 VOTING AGREEMENT & CERTAIN ENTITIES AFFILIATED WITH PERRY CORP. dex993.htm EX-99.3 86480
6 REGISTRATION RIGHTS AGREEMENT dex994.htm EX-99.4 69144
7 JOINT PRESS RELEASE dex995.htm EX-99.5 24952
8 GRAPHIC g70625image001.jpg GRAPHIC 21608
9 GRAPHIC g70625image002.jpg GRAPHIC 30016
  Complete submission text file 0001193125-04-173865.txt   623515
Mailing Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650.635.1100
VIROLOGIC INC (Filer) CIK: 0001094961 (see all company filings)

IRS No.: 943234479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30369 | Film No.: 041086040
SIC: 2835 In Vitro & In Vivo Diagnostic Substances